CA2463446C - Use of (11.beta., 17.beta.)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-one in the treatment of major depressive disorder - Google Patents

Use of (11.beta., 17.beta.)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-one in the treatment of major depressive disorder Download PDF

Info

Publication number
CA2463446C
CA2463446C CA2463446A CA2463446A CA2463446C CA 2463446 C CA2463446 C CA 2463446C CA 2463446 A CA2463446 A CA 2463446A CA 2463446 A CA2463446 A CA 2463446A CA 2463446 C CA2463446 C CA 2463446C
Authority
CA
Canada
Prior art keywords
beta
treatment
estra
dien
propynyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2463446A
Other languages
English (en)
French (fr)
Other versions
CA2463446A1 (en
Inventor
Cornelis Sennef
Bernardus Wijnand Mathys Marie Peeters
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pop Test Cortisol LLC
Original Assignee
Organon NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon NV filed Critical Organon NV
Publication of CA2463446A1 publication Critical patent/CA2463446A1/en
Application granted granted Critical
Publication of CA2463446C publication Critical patent/CA2463446C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA2463446A 2001-10-26 2002-10-21 Use of (11.beta., 17.beta.)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-one in the treatment of major depressive disorder Expired - Fee Related CA2463446C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01204072.1 2001-10-26
EP01204072 2001-10-26
PCT/EP2002/011732 WO2003037354A1 (en) 2001-10-26 2002-10-21 USE OF (11β, 17β)-11-(1,3-BENZODIOXOL-5-YL)-17-HYDROXY-17-(1-PROPYNYL)-ESTRA-4,9-DIEN-3-ONE IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER

Publications (2)

Publication Number Publication Date
CA2463446A1 CA2463446A1 (en) 2003-05-08
CA2463446C true CA2463446C (en) 2010-02-23

Family

ID=8181136

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2463446A Expired - Fee Related CA2463446C (en) 2001-10-26 2002-10-21 Use of (11.beta., 17.beta.)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-one in the treatment of major depressive disorder

Country Status (26)

Country Link
US (1) US20040266863A1 (https=)
EP (2) EP1652526B1 (https=)
JP (1) JP4647909B2 (https=)
KR (1) KR20050038580A (https=)
CN (1) CN100531738C (https=)
AT (2) ATE317700T1 (https=)
AU (1) AU2002348996B2 (https=)
BR (1) BR0213466A (https=)
CA (1) CA2463446C (https=)
CY (1) CY1110173T1 (https=)
DE (2) DE60230936D1 (https=)
DK (1) DK1652526T3 (https=)
EC (1) ECSP045080A (https=)
ES (1) ES2319563T3 (https=)
HR (1) HRP20040370B1 (https=)
HU (1) HUP0500070A3 (https=)
IL (2) IL161248A0 (https=)
IS (1) IS2702B (https=)
MX (1) MXPA04003781A (https=)
NO (1) NO332978B1 (https=)
NZ (1) NZ532429A (https=)
PL (1) PL206687B1 (https=)
PT (1) PT1652526E (https=)
RU (1) RU2302245C2 (https=)
WO (1) WO2003037354A1 (https=)
ZA (1) ZA200403088B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050080061A1 (en) * 2003-07-23 2005-04-14 Corcept Therapeutics, Inc. Antiglucocorticoid therapy for the prevention of neurological damage in premature infants
EP2292269A3 (en) * 2004-11-19 2011-08-10 N.V. Organon Drug combination comprising a selective serotonin reuptake inhibitor and a glucocorticoid receptor antagonist for the treatment of depression
AU2011236053B2 (en) * 2004-11-19 2014-06-26 Merck Sharpe & Dohme B.V. Drug combination comprising a selective serotonin reuptake inhibitor and a glucocorticoid receptor antagonist for the treatment of depression
JP2009535430A (ja) * 2006-05-02 2009-10-01 コーセプト セラピューティクス， インコーポレイテッド Ｉｌ−２を摂取している患者における抑うつを処置するためのグルココルチコイドレセプターｉｉアンタゴニストの使用
EP2671086B1 (en) * 2011-02-03 2018-04-25 Pop Test Oncology LLC System and method for diagnosis and treatment
US20120263660A1 (en) * 2011-04-18 2012-10-18 Pop Test Cortisol Llc Hair Loss Treatment
US8986677B2 (en) * 2012-07-30 2015-03-24 Pop Test Cortisol Llc Therapeutic compositions and methods

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4814333A (en) * 1987-07-28 1989-03-21 The Trustees Of Dartmouth College Method for treatment of hypercortisolemic, depressed patients
DE4447401A1 (de) * 1994-12-23 1996-07-04 Schering Ag 14,17-C¶2¶-überbrückte Steroide
IL118974A (en) * 1995-08-17 2001-09-13 Akzo Nobel Nv History 11 - (Transformed Phenyl) - Astra - 4, 9 - Diane, their preparation and pharmaceutical preparations containing them
DE19727772A1 (de) * 1997-06-30 1999-01-28 Forschungszentrum Juelich Gmbh Magnetflußsensor mit ringförmiger Sonde
ATE332696T1 (de) * 1997-10-06 2006-08-15 Univ Leland Stanford Junior Methode zur behandlung von durch glycocorticoidstörungen verursachten psychosen
CN1820756A (zh) * 2001-03-23 2006-08-23 科塞普特治疗公司 使用糖皮质激素受体特效拮抗剂治疗压力症的方法
DE60238671D1 (de) * 2001-05-04 2011-02-03 Corcept Therapeutics Inc Verwendung von glucocorticoid-rezeptor-spezifischen antagonisten zur behandlung von delirium
IL160649A0 (en) * 2001-08-31 2004-07-25 Corcept Therapeutics Inc Methods for inhibiting cognitive deterioration in adults with down syndrome

Also Published As

Publication number Publication date
EP1441739B1 (en) 2006-02-15
IL161248A (en) 2010-12-30
NO332978B1 (no) 2013-02-11
EP1652526A2 (en) 2006-05-03
US20040266863A1 (en) 2004-12-30
WO2003037354A1 (en) 2003-05-08
EP1652526A3 (en) 2006-08-02
DE60230936D1 (de) 2009-03-05
HUP0500070A2 (hu) 2005-04-28
ECSP045080A (es) 2004-06-28
PT1652526E (pt) 2009-02-06
ZA200403088B (en) 2005-01-24
NO20041651L (no) 2004-04-23
RU2302245C2 (ru) 2007-07-10
CN100531738C (zh) 2009-08-26
BR0213466A (pt) 2004-11-09
IS7204A (is) 2004-03-31
ATE420649T1 (de) 2009-01-15
CA2463446A1 (en) 2003-05-08
CY1110173T1 (el) 2015-01-14
JP2005521637A (ja) 2005-07-21
HRP20040370A2 (en) 2004-08-31
EP1652526B1 (en) 2009-01-14
KR20050038580A (ko) 2005-04-27
HUP0500070A3 (en) 2012-09-28
PL206687B1 (pl) 2010-09-30
HRP20040370B1 (hr) 2012-09-30
CN1582153A (zh) 2005-02-16
JP4647909B2 (ja) 2011-03-09
NZ532429A (en) 2004-10-29
ATE317700T1 (de) 2006-03-15
IS2702B (is) 2010-11-15
DK1652526T3 (da) 2009-05-18
ES2319563T3 (es) 2009-05-08
IL161248A0 (en) 2004-09-27
HK1087357A1 (en) 2006-10-13
EP1441739A1 (en) 2004-08-04
PL369261A1 (en) 2005-04-18
AU2002348996B2 (en) 2008-06-05
DE60209248D1 (de) 2006-04-20
RU2004116082A (ru) 2005-05-10
MXPA04003781A (es) 2004-07-30

Similar Documents

Publication Publication Date Title
AU624082B2 (en) Compounds having antiprogestational and anti-estrogenic activities for the treatment of hormone-dependent tumors
TWI477276B (zh) 抗黃體素給藥方案
EP3263112B1 (en) Compositions and methods for suppressing endometrial proliferations
CA2463446C (en) Use of (11.beta., 17.beta.)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-one in the treatment of major depressive disorder
US8193172B2 (en) Methods for the treatment of major depressive disorder using glucocorticoid receptor antagonists
Rapkin et al. Oral contraceptives and neuroactive steroids
AU2002348996A1 (en) Use of (11beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-one in the treatement of major depressive disorder
HK1087357B (en) Use of (11beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-one in the treatment of major depressive disorder
US20090118253A1 (en) Compositions and methods for treating dysfunctional uterine bleeding
Loriaux¹ Lynnette K. Nieman, 1 George rge P. Chrousos, 1 Charles

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20151021